Not every patient benefits equally from acute care delivered at home. Program impact concentrates in a subset of the population, and identifying that subset in advance determines whether a program produces measurable results.
The most reliable predictor is not age or diagnosis. It is the number of chronic conditions a patient carries simultaneously.
What Does Multimorbidity Change Clinically?
A patient with a single chronic condition experiencing an acute problem generally presents a contained clinical picture. A patient with four interacting conditions presents a problem where the acute issue and the baseline are difficult to separate.
That difficulty is exactly what a brief encounter handles poorly. Distinguishing new from baseline requires history and context that a compressed visit cannot gather.
Why Do Emergency Departments Struggle With This Population?
Emergency departments are designed to identify and treat immediate threats efficiently. That design works well for isolated acute problems and less well for acute problems layered on complex baselines.
The analysis in access to care for medically complex patients connects this mismatch to the disproportionate emergency department utilization observed in multimorbid populations, where the setting best equipped for emergencies is a poor fit for complexity. The volume concentrates where the fit is worst.
Without prior history, an emergency clinician frequently cannot determine what is new. The conservative response is admission or extensive workup.
What Does the Utilization Data Show?
In the Massachusetts program’s 2025 results, more than half of patients carried two or more chronic conditions or a medical complexity flag. That concentration reflects who actually generates avoidable acute episodes.
It also indicates the program was reaching the population where impact is possible. Serving a lower-complexity group would produce activity without utilization effect.
Why Does the Home Setting Suit This Population?
A home encounter supplies context that facility settings cannot access. Medication inventory, living conditions, and caregiver observations are directly available rather than reconstructed.
For a multimorbid patient, that context frequently determines the assessment. The distinction between decompensation and a new problem often lives in those details.
How Does Encounter Length Interact With Complexity?
Extended encounters matter more as complexity increases. A 75-minute visit adds little to a straightforward presentation and considerable value to a complicated one.
This is why encounter length and population complexity should be evaluated together. Long visits to simple cases are inefficiency rather than thoroughness.
What Predicts Benefit Most Reliably?
Several patient characteristics correlate with meaningful benefit from in-home acute care:
- Two or more chronic conditions managed concurrently
- A history of repeated emergency department utilization
- Functional or mobility limitation affecting travel
- Complex medication regimens with interaction potential
- Behavioral health or substance use history alongside medical need
Patients carrying several of these are where program impact concentrates. Targeting enrollment toward them improves measured results substantially.
How Should Programs Use This for Targeting?
Health plans generally have the claims data required to identify multimorbid members before an acute episode occurs. Proactive outreach to that group is more effective than waiting for calls.
Programs relying entirely on inbound volume will serve whoever happens to call. That population may not match where impact is greatest.
Does This Mean Lower-Complexity Patients Should Be Excluded?
Excluding lower-complexity patients would undermine the direct access that makes the model reachable. A program that turns away straightforward cases becomes difficult for patients to use.
The distinction is between who is served and where impact is measured. Serving a broad population while measuring effect in the high-complexity subset is generally the sound approach.
How Does This Affect Contracting?
Contracts structured around utilization reduction should specify the population in which reduction is measured. A program serving a mixed population will show diluted effects if measured across everyone.
Utilization findings reported in the 2025 mobile integrated health outcomes specify reductions among high-risk populations rather than across the entire served group, which is the appropriate basis for evaluating a program targeting complexity. Measuring the right subgroup is what makes the effect visible.
Measuring across an undifferentiated population understates real impact. Defining the measured cohort during contracting prevents that outcome.
What Should Plans Do With This?
Plans should use existing risk stratification to identify members most likely to benefit and route outreach accordingly. The data required generally already exists in claims systems.
Combining proactive targeting with open access captures both impact and reachability. Neither alone produces the full result.
How Do Social Factors Interact With Clinical Complexity?
Housing instability, food insecurity, and absent caregiver support compound clinical complexity in ways that are invisible in claims data. A home visit surfaces these directly.
Programs that document social observations back to the longitudinal care team convert a single encounter into information the health plan can act on. That routing is where much of the durable value originates.
What Happens When Targeting Is Too Narrow?
Programs that restrict access exclusively to a high-risk list become difficult for patients to use and lose the direct accessibility that drives volume. Narrow targeting can undermine the access model it was meant to focus.
Most programs resolve this by keeping access open while directing proactive outreach toward high-complexity members. The two approaches serve different purposes and work better together.
Chronic condition count predicts benefit from in-home acute care more reliably than age or diagnosis. The model’s advantages compound as complexity increases.
For plans and programs, the practical implication is to target enrollment and measurement toward multimorbid members while keeping access open. That combination is where measurable utilization effects appear.
